Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

INTRODUCTION: We evaluated the three-year impact of adalimumab on patient-reported physical function and health-related quality-of-life (HRQOL) outcomes in patients with active ankylosing spondylitis (AS). METHODS: The Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS (ATLAS) is an ong...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: van der Heijde, Désirée M, Revicki, Dennis A, Gooch, Katherine L, Wong, Robert L, Kupper, Hartmut, Harnam, Neesha, Thompson, Chris, Sieper, Joachim
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2009
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745808/
https://ncbi.nlm.nih.gov/pubmed/19686597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2790
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi